Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 387-392

  Li, Yan Chun ^a   Qiao, Guilin ^a   Uskokovic, Milan ^b   Xiang, Wei ^a   Zheng, Wei ^a   Kong, Juan ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Bioxell Inc   (United States)

Author keywords

Angiotensin; Hypertension; Renin; Vitamin D; Vitamin D analogs

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITRIOL; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; RENIN; SODIUM CHLORIDE; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; WATER;

BLOOD PRESSURE REGULATION; CALCIUM METABOLISM; CELL CULTURE; CONFERENCE PAPER; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENDOCRINE SYSTEM; FEEDBACK SYSTEM; FLUID INTAKE; GENE REPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HEART HYPERTROPHY; HOMEOSTASIS; HUMAN; HYPERTENSION; INJECTION; METHODOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEQUENCE ANALYSIS; STIMULATION; TOXICITY; TRANSCRIPTION REGULATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

BLOOD PRESSURE; HUMANS; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 3042594296     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.004     Document Type: Conference Paper

References (53)

1. DeLuca H.F. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J. 2:1988;224-236
2. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.-C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13:1998;325-349
3. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., Masushige S., Fukamizu A., Matsumoto T., Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation. Nat Genet. 16:1997;391-396
4. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., Goltzman D. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7498-7503
5. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., Demay M.B. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9831-9835
6. Dardenne O., Prud'homme J., Arabian A., Glorieux F.H., St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology. 142:2001;3135-3141
7. Zinser G., Packman K., Welsh J. Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development. 129:2002;3067-3076
8. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1, 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110:2002;229-238
9. Kong J., Li Y.C. Effect of angiotensin II type I receptor antagonist and angiotensin-converting enzyme inhibitor on vitamin D receptor null mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285:2003;R255-R261
10. Berry C., Touyz R., Dominiczak A.F., Webb R.C., Johns D.G. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am. J. Physiol. Heart Circ. Physiol. 281:2001;H2337-H2365
11. B.J. Ballermann, M.L. Zeidel, M.E. Gunning, B.M. Brenner, Vasoactive peptides and the kidney, in: B.M. Brenner, F.C. Rector (Eds.), The kidney, W.B. Saunders Company, Philadelphia, 1991, pp. 510-583.
12. Lavoie J.L., Sigmund C.D. Minireview: overview of the Renin-angiotensin system-an endocrine and paracrine system. Endocrinology. 144:2003;2179-2183
13. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109:2002;1417-1427
14. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R.E., Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87:2000;E1-E9
15. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275:2000;33238-33243
16. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., Oliveira-dos-Santos A.J., da Costa J., Zhang L., Pei Y., Scholey J., Ferrario C.M., Manoukian A.S., Chappell M.C., Backx P.H., Yagil Y., Penninger J.M. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 417:2002;822-828
17. Hackenthal E., Paul M., Ganten D., Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol. Rev. 70:1990;1067-1116
18. Bader M., Ganten D. Regulation of renin: new evidence from cultured cells and genetically modified mice [in process citation]. J. Mol. Med. 78:2000;130-139
19. Tamura K., Chen Y.E., Horiuchi M., Chen Q., Daviet L., Yang Z., Lopez-Ilasaca M., Mu H., Pratt R.E., Dzau V.J. LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression. Proc. Natl. Acad. Sci. U.S.A. 97:2000;8513-8518
20. Shi Q., Gross K.W., Sigmund C.D. Retinoic acid-mediated activation of the mouse renin enhancer. J. Biol. Chem. 276:2001;3597-3603
21. Pan L., Black T.A., Shi Q., Jones C.A., Petrovic N., Loudon J., Kane C., Sigmund C.D., Gross K.W. Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J. Biol. Chem. 276:2001;45530-45538
22. Pan L., Xie Y., Black T.A., Jones C.A., Pruitt S.C., Gross K.W. An Abd-B class HOX.PBX recognition sequence is required for expression from the mouse Ren-1c gene. J. Biol. Chem. 276:2001;32489-32494
23. Liu X., Huang X., Sigmund C.D. Identification of a nuclear orphan receptor (Ear2) as a negative regulator of renin gene transcription. Circ. Res. 92:2003;1033-1040
24. Rostand S.G. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 30:1997;150-156
25. He J., Klag M.J., Wu Z., Whelton P.K. Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors. Stroke. 26:1995;2222-2227
26. Kunes J., Tremblay J., Bellavance F., Hamet P. Influence of environmental temperature on the blood pressure of hypertensive patients in Montreal. Am. J. Hypertens. 4:1991;422-426
27. Woodhouse P.R., Khaw K.T., Plummer M. Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. J. Hypertens. 11:1993;1267-1274
28. Holick M.F. Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed. Proc. 46:1987;1876-1882
29. Harburg E., Gleibermann L., Roeper P., Schork M.A., Schull W.J. Skin color, ethnicity, and blood pressure I: detroit blacks. Am. J. Public Health. 68:1978;1177-1183
30. Klag M.J., Whelton P.K., Coresh J., Grim C.E., Kuller L.H. The association of skin color with blood pressure in US blacks with low socioeconomic status. JAMA. 265:1991;599-602
31. Krause R., Buhring M., Hopfenmuller W., Holick M.F., Sharma A.M. Ultraviolet B and blood pressure. Lancet. 352:1998;709-710
32. Kristal-Boneh E., Froom P., Harari G., Ribak J. Association of calcitriol and blood pressure in normotensive men. Hypertension. 30:1997;1289-1294
33. Lind L., Hanni A., Lithell H., Hvarfner A., Sorensen O.H., Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am. J. Hypertens. 8:1995;894-901
34. Burgess E.D., Hawkins R.G., Watanabe M. Interaction of 1, 25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am. J. Hypertens. 3:1990;903-905
35. Resnick L.M., Muller F.B., Laragh J.H. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann. Intern. Med. 105:1986;649-654
36. Lind L., Wengle B., Wide L., Ljunghall S. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am. J. Hypertens. 2:1989;20-25
37. Pfeifer M., Begerow B., Minne H.W., Nachtigall D., Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J. Clin. Endocrinol. Metab. 86:2001;1633-1637
38. Kimura Y., Kawamura M., Owada M., Oshima T., Murooka M., Fujiwara T., Hiramori K. Effectiveness of 1, 25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity. Intern. Med. 38:1999;31-35
39. Park C.W., Oh Y.S., Shin Y.S., Kim C.M., Kim Y.S., Kim S.Y., Choi E.J., Chang Y.S., Bang B.K. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am. J. Kidney Dis. 33:1999;73-81
40. Gunther T., Chen Z.F., Kim J., Priemel M., Rueger J.M., Amling M., Moseley J.M., Martin T.J., Anderson D.J., Karsenty G. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature. 406:2000;199-203
41. Kong J., Li X.J., Gavin D., Jiang Y., Li Y.C. Targeted expression of human vitamin D receptor in the skin promotes the initiation of postnatal hair follicular cycle and rescue the alopecia in vitamin D receptor null mice. J. Invest. Dermatol. 118:2002;631-638
42. Silver J., Naveh-many T., Mayer H., Schmeizer H.J., Popovtzer M.M. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J. Clin. Invest. 78:1986;1296-1301
43. Omdahl J.L., DeLuca H.F. Strontium induced rickets: metabolic basis. Science. 174:1971;949-951
44. Sigmund C.D., Okuyama K., Ingelfinger J., Jones C.A., Mullins J.J., Kane C., Kim U., Wu C.Z., Kenny L., Rustum Y., et al. Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. J. Biol. Chem. 265:1990;19916-19922
45. August P. Initial treatment of hypertension. N. Engl. J. Med. 348:2003;610-617
46. Brunner H.R., Laragh J.H., Baer L., Newton M.A., Goodwin F.T., Krakoff L.R., Bard R.H., Buhler F.R. Essential hypertension: renin and aldosterone, heart attack and stroke. N. Engl. J. Med. 286:1972;441-449
47. Esler M., Julius S., Zweifler A., Randall O., Harburg E., Gardiner H., DeQuattro V. Mild high-renin essential hypertension. Neurogenic human hypertension? N. Engl. J. Med. 296:1977;405-411
48. Kokubu T., Ueda E., Fujimoto S., Hiwada K., Kato A. Peptide inhibitors of the renin-angiotensin system. Nature. 217:1968;456-457
49. Poulsen K., Burton J., Haber E. Purification of hog renin by affinity chromatography using the synthetic competitive inhibitor (D-Leu6)octapeptide. Biochim. Biophys. Acta. 400:1975;258-262
50. Burton J., Cody R.J. Jr., Herd J.A., Haber E. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension. Proc. Natl. Acad. Sci. U.S.A. 77:1980;5476-5479
51. Brown A.J., Dusso A.S., Slatopolsky E. Vitamin D analogues for secondary hyperparathyroidism. Nephrol. Dial Transplant. 17(Suppl 10):2002;10-19
52. Malluche H.H., Mawad H., Koszewski N.J. Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure. Kidney Int. 62:2002;367-374
53. M.R. Uskokovic, P.S. Manchand, S. Peleg, A.W. Norman, Synthesis and preliminary evaluation of the biological properties of a 1a, 25-dihydroxyvitamin D3 analog with two side chains, in: A.W. Norman, R. Bouillon, M. Thomasset (Eds.), Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, University of California, Riverside, 1997, pp. 19-21.